文献速递胃肠外科围术期管理与 ERAS

3D与2D腹腔镜胃癌手术临床结局随机对照试验中期报告

Randomized, controlled trial comparing clinical outcomes of 3D and 2D laparoscopic surgery for gastric cancer: an interim report.
PubMed 文献 · Surg Endosc · 2016-11-08

一项单中心III期前瞻性随机对照试验比较3D与2D腹腔镜胃癌手术的短期结局,共228例随机分组、221例纳入分析。两组手术时间、淋巴结清扫数、术后恢复指标及并发症率均无显著差异,但3D组术中出血量显著低于2D组。

要点

  • 3D与2D腹腔镜胃癌手术在手术时间和淋巴结清扫数上无显著差异
  • 3D组术中出血量显著低于2D组(58±75 vs 78±72 ml,P=0.047)
  • 两组术后并发症率与住院时间无显著差异,试验安全性良好并继续进行

核心结论

  • 3D与2D腹腔镜胃癌手术在手术时间和淋巴结清扫数上无显著差异,3D腹腔镜手术可能减少术中出血量。
  • 研究者认为该试验是安全的,因此试验仍在进行中。

研究设计与样本

  • III期单中心前瞻性随机对照试验,研究注册号ClinicalTrials.gov NCT02327481。
  • 2015年1月1日至2015年9月1日共随机228例(3D组115例,2D组113例),排除7例探查手术者,最终分析221例(3D组109例,2D组112例)。
  • 比较两组手术时间、术中出血量、淋巴结清扫数、并发症率与死亡率。

主要发现

  • 手术时间3D vs 2D为184±36 vs 178±37 min,P=0.288。
  • 淋巴结清扫数36±14 vs 37±13,P=0.698。
  • 术中出血量3D组显著低于2D组(58±75 vs 78±72 ml,P=0.047)。
  • 术后并发症率18.3% vs 16.1%,P=0.723;术后住院期间无患者死亡。
  • 首次下床时间、排气、流质饮食及术后住院时间两组差异均无统计学意义。

临床怎么用

  • 在胃癌腹腔镜手术中,3D与2D系统均可安全使用,短期肿瘤学相关指标(淋巴结清扫数)与手术时间相当。
  • 对术中出血风险较高的病例,可考虑选用3D腹腔镜以减少出血。

局限性

  • 本文为中期报告,样本量有限,最终结论需等待试验完成。
  • 为单中心研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In this study, we evaluated the short-term outcomes following three-dimensional (3D) or two-dimensional (2D) laparoscopic surgery for patients with gastric cancer. BACKGROUND: There is a lack of prospective evidence regarding the safety and efficacy of 3D versus 2D laparoscopic surgery for patients with gastric cancer. Therefore, we conducted a phase III single-center, prospective, randomized, controlled trial to compare 3D and 2D laparoscopic surgery for patients with gastric cancer. METHODS: We compared operation time, intraoperative blood loss, number of lymph node dissections, morbidity, and mortality between the 3D and 2D groups following laparoscopic surgery for gastric cancer. The study is registered at ClinicalTrials.gov with ID number NCT02327481. RESULTS: A total of 228 patients were randomized (3D group 115 cases; 2D group 113 cases) between January 1, 2015 and September 1, 2015. Seven patients who underwent exploratory operations were excluded. Finally, a total of 221 patients were analyzed (3D group 109 cases, 2D group 112 cases). There were no significant differences between the two groups regarding the clinical pathological characteristics, operating time (3D vs. 2D, 184 ± 36 vs. 178 ± 37 min, P = 0.288), number of lymph node dissections (36 ± 14 vs. 37 ± 13, P = 0.698), time to first ambulation (2.27 ± 1.60 vs. 2.04 ± 0.84, P = 0.18), flatus (3.89 ± 1.49 vs. 3.69 ± 1.12, P = 0.255), liquid diet (4.88 ± 1.88 vs. 4.79 ± 1.57, P = 0.684), or duration of postoperative hospital stay (12.52 ± 4.83 vs. 12.63 ± 7.32, P = 0.903). The postoperative complication rates of the 3D and 2D groups were 18.3 and 16.1%, respectively, P = 0.723. No patients died during the postoperative hospital stay. However, the intraoperative blood loss in the 3D group was significantly lower than the 2D group (58 ± 75 vs. 78 ± 72 ml, P = 0.047). CONCLUSION: There was no significant difference in operation time and number of lymph node harvested between the 3D and 2D groups; however, 3D laparoscopic surgery may reduce the intraoperative blood loss compared to 2D procedure. Therefore, we conclude that this trial is safe and is thus ongoing.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Lu J, Zheng CH, Zheng HL, et al. Randomized, controlled trial comparing clinical outcomes of 3D and 2D laparoscopic surgery for gastric cancer: an interim report. Surg Endosc. 2016. PMID: 27826781. doi:10.1007/s00464-016-5310-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。